Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα
Elisavet Serti, Heiyoung Park, Meghan Keane, Ashley C O'Keefe, Elenita Rivera, T Jake Liang, Marc Ghany, Barbara Rehermann, Elisavet Serti, Heiyoung Park, Meghan Keane, Ashley C O'Keefe, Elenita Rivera, T Jake Liang, Marc Ghany, Barbara Rehermann
Abstract
Objective: Chronic HCV infection is characterised by innate immune activation with increased interferon-stimulated genes (ISG) expression and by an altered phenotype of interferon-responsive natural killer (NK) cells. Here, we asked whether a rapid reduction in viremia by daclatasvir (DCV) and asunaprevir (ASV) improves the response to pegylated interferon (PegIFN) in patients who had previously failed a standard course of PegIFN/ribavirin (RBV) therapy.
Design: Twenty-two HCV-infected non-responders to previous PegIFN/RBV therapy were studied for IFN-responsiveness of NK cells during quadruple (QUAD) therapy with DCV, ASV, PegIFN and RBV. A direct comparison of early NK cell responses in PegIFN/RBV therapy and QUAD therapy was performed for seven patients using paired cryopreserved peripheral blood mononuclear cells (PBMC) from both treatment courses. As a validation cohort, nine DCV/ASV-treated patients were studied for their NK cell response to in vitro stimulation with IFNα.
Results: The 24 h virological response to QUAD therapy correlated with an increase in signal transducer and activator of transcription 1 (STAT1), phosphorylated STAT1 (pSTAT1) and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) expression in NK cells, and the STAT1/pSTAT1/TRAIL induction was greater during QUAD therapy than during previous PegIFN/RBV therapy. Successful QUAD therapy as well as successful IFN-free DCV/ASV regimen resulted in an improved functional NK cell response (degranulation and TRAIL expression) to in vitro stimulation with IFNα.
Conclusions: IFN-responsiveness can be improved by inhibiting HCV replication and reducing the HCV-induced activation of the innate immune response. This may provide a rationale for clinical trials of a brief period of direct acting antiviral therapy followed by PegIFN/RBV therapy to reduce the overall treatment costs in low-income and middle-income countries.
Trial registration numbers: NCT01888900 and NCT00718172.
Keywords: HEPATITIS C; IMMUNE RESPONSE; IMMUNOLOGY; IMMUNOLOGY IN HEPATOLOGY.
Conflict of interest statement
COMPETING INTERESTS
The authors do not have a commercial or other association that might pose a conflict of interest.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Figures









Source: PubMed
Prochains essais cliniques
-
Shirley Ryan AbilityLabKiwanis Neurological Research FoundationRecrutementTraumatisme crânien TBIÉtats-Unis
-
University of ChicagoNational Heart, Lung, and Blood Institute (NHLBI)Pas encore de recrutementThromboembolie veineuse | Chirurgie du pelvis | Chirurgie du cancer de l'abdomenÉtats-Unis
-
Fundacion para la Investigacion Biomedica del Hospital...Hospital Universitario La FeRecrutement
-
Lumetry Diagnostics GmbHKarl Landsteiner Institute for Lung Research and Pneumological Oncology; Klinik...Pas encore de recrutementMaladie pulmonaire obstructive chronique | HypercapnieL'Autriche
-
Beijing Suncadia Pharmaceuticals Co., LtdRecrutementLa maladie d'AlzheimerChine
-
IpsenPas encore de recrutementCancer de la prostate
-
Xiangya Hospital of Central South UniversityPas encore de recrutementPsoriasis en plaques | DyslipidémieChine
-
Halic UniversityPas encore de recrutementQualité du sommeil | Intervention diététique | Stress perçu | Brouillard cérébralTurquie (Türkiye)
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPas encore de recrutementCancer du sein métastatique | Cancer du sein à récepteurs hormonaux positifs | Cancer du sein HER2-faibleChine
-
The 108 Military Central HospitalVietnam Military Medical University; Thanh Phuong Co., LtdPas encore de recrutementChoc septique | Lésion rénale aiguëViêt Nam
-
University Hospital, MontpellierPas encore de recrutementHémiparésie | Spasticité | Spasticité des membres supérieursFrance
-
Kasr El Aini HospitalRecrutementMastite granulomateuse idiopathiqueEgypte